Fuminari Misawa

893 total citations
28 papers, 488 citations indexed

About

Fuminari Misawa is a scholar working on Psychiatry and Mental health, Clinical Psychology and Philosophy. According to data from OpenAlex, Fuminari Misawa has authored 28 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 5 papers in Clinical Psychology and 5 papers in Philosophy. Recurrent topics in Fuminari Misawa's work include Schizophrenia research and treatment (23 papers), Bipolar Disorder and Treatment (11 papers) and Electroconvulsive Therapy Studies (7 papers). Fuminari Misawa is often cited by papers focused on Schizophrenia research and treatment (23 papers), Bipolar Disorder and Treatment (11 papers) and Electroconvulsive Therapy Studies (7 papers). Fuminari Misawa collaborates with scholars based in Japan, United States and Canada. Fuminari Misawa's co-authors include Christoph U. Correll, John M. Kane, Taishiro Kishimoto, Hiroyoshi Takeuchi, Katsuhiko Hagi, Takahiro Masuda, Masayuki Takase, Yasuo Fujii, Gary Remington and Yasuyuki Okumura and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychiatry Research.

In The Last Decade

Fuminari Misawa

25 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuminari Misawa Japan 9 431 93 93 90 38 28 488
F. Cañas Spain 9 323 0.7× 50 0.5× 98 1.1× 57 0.6× 34 0.9× 25 453
Corina Young United Kingdom 9 530 1.2× 84 0.9× 102 1.1× 154 1.7× 92 2.4× 11 630
W. Chrzanowski Poland 7 413 1.0× 126 1.4× 96 1.0× 110 1.2× 22 0.6× 11 497
Shubhra Mace United Kingdom 9 277 0.6× 125 1.3× 93 1.0× 55 0.6× 14 0.4× 14 467
Maila Majak Sweden 6 581 1.3× 77 0.8× 176 1.9× 172 1.9× 60 1.6× 8 734
Ralph Aquila United States 10 357 0.8× 77 0.8× 111 1.2× 77 0.9× 27 0.7× 15 446
Eun Kee Chung South Korea 11 347 0.8× 80 0.9× 107 1.2× 88 1.0× 15 0.4× 15 454
Colette Kosik‐Gonzalez United States 10 375 0.9× 167 1.8× 72 0.8× 47 0.5× 16 0.4× 18 558
R.N. Marcus United States 5 396 0.9× 71 0.8× 59 0.6× 48 0.5× 48 1.3× 10 449
C.U. Correll United States 5 312 0.7× 58 0.6× 81 0.9× 77 0.9× 12 0.3× 17 377

Countries citing papers authored by Fuminari Misawa

Since Specialization
Citations

This map shows the geographic impact of Fuminari Misawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuminari Misawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuminari Misawa more than expected).

Fields of papers citing papers by Fuminari Misawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuminari Misawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuminari Misawa. The network helps show where Fuminari Misawa may publish in the future.

Co-authorship network of co-authors of Fuminari Misawa

This figure shows the co-authorship network connecting the top 25 collaborators of Fuminari Misawa. A scholar is included among the top collaborators of Fuminari Misawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuminari Misawa. Fuminari Misawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Misawa, Fuminari, et al.. (2024). Intentional non-adherence to antipsychotic medication in patients with schizophrenia. Schizophrenia Research. 274. 427–432.
2.
Misawa, Fuminari, et al.. (2023). Appendicitis Associated With Clozapine. Journal of Clinical Psychopharmacology. 43(3). 228–232. 2 indexed citations
3.
Misawa, Fuminari, Yasuo Fujii, & Hiroyoshi Takeuchi. (2022). Tardive Dyskinesia and Long-Acting Injectable Antipsychotics. The Journal of Clinical Psychiatry. 83(5). 3 indexed citations
4.
So, Ryuhei, Fuminari Misawa, Manabu Kodama, et al.. (2022). Clozapine Once-Daily Versus Divided Dosing Regimen: A Cross-sectional Study in Japan.. PubMed. 42(2). 163–168. 1 indexed citations
5.
Guinart, Daniel, Fuminari Misawa, José M. Rubio, et al.. (2021). A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome. Acta Psychiatrica Scandinavica. 144(4). 329–341. 30 indexed citations
6.
Hatta, Kotaro, Yasuhiko Sudo, Mitsuru Nakamura, et al.. (2021). Real-world effectiveness of antipsychotic treatments in 1011 acutely hospitalized patients with schizophrenia: A one-year follow-up study. Asian Journal of Psychiatry. 67. 102917–102917. 2 indexed citations
7.
Misawa, Fuminari, et al.. (2021). Development of diagnostic criteria and severity scale for polydipsia: A systematic literature review and well-experienced clinicians’ consensus. Psychiatry Research. 297. 113708–113708. 1 indexed citations
8.
Misawa, Fuminari, Yasuyuki Okumura, Yoshinori Takeuchi, Yasuo Fujii, & Hiroyoshi Takeuchi. (2021). Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophrenia Research. 231. 42–46. 7 indexed citations
9.
Watanabe, Maiko, et al.. (2021). Clinical outcomes after clozapine discontinuation in responders versus nonresponders: a retrospective chart review. International Clinical Psychopharmacology. 36(4). 188–192. 2 indexed citations
10.
So, Ryuhei, Yuya Mizuno, Fuminari Misawa, et al.. (2020). Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J). PLoS ONE. 15(6). e0234864–e0234864. 4 indexed citations
11.
Guinart, Daniel, Fuminari Misawa, José M. Rubio, et al.. (2020). Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics. The Journal of Clinical Psychiatry. 82(1). 17 indexed citations
12.
13.
Misawa, Fuminari, Toru Yamashita, Ryuhei So, et al.. (2020). Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychotics. International Clinical Psychopharmacology. 36(2). 84–88. 3 indexed citations
14.
15.
Misawa, Fuminari, et al.. (2019). Long-Acting Injectables Versus Oral Antipsychotics. Journal of Clinical Psychopharmacology. 39(5). 441–445. 13 indexed citations
16.
Hatta, Kotaro, Hana Hasegawa, Atsushi Imai, et al.. (2019). Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia. Asian Journal of Psychiatry. 40. 82–87. 19 indexed citations
17.
Misawa, Fuminari, et al.. (2019). Relationship between polydipsia and antipsychotics: A systematic review of clinical studies and case reports. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 96. 109756–109756. 13 indexed citations
18.
Masuda, Takahiro, Fuminari Misawa, Masayuki Takase, John M. Kane, & Christoph U. Correll. (2019). Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics. JAMA Psychiatry. 76(10). 1052–1052. 96 indexed citations
19.
Misawa, Fuminari, Takefumi Suzuki, & Yasuo Fujii. (2017). Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion. Journal of Clinical Psychopharmacology. 37(6). 664–668. 2 indexed citations
20.
Misawa, Fuminari, Taishiro Kishimoto, Katsuhiko Hagi, John M. Kane, & Christoph U. Correll. (2016). Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics. Schizophrenia Research. 176(2-3). 220–230. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Cañas Breakdown of academic impact, for papers by Corina Young Breakdown of academic impact, for papers by W. Chrzanowski Breakdown of academic impact, for papers by Shubhra Mace Breakdown of academic impact, for papers by Maila Majak Breakdown of academic impact, for papers by Ralph Aquila Breakdown of academic impact, for papers by Eun Kee Chung Breakdown of academic impact, for papers by Colette Kosik‐Gonzalez Breakdown of academic impact, for papers by R.N. Marcus Breakdown of academic impact, for papers by C.U. Correll
Rankless by CCL
2026